Systemic lupus erythematosus (SLE)-related TMA includes both acquired TTP, in which ADAMTS13 activity is significantly reduced, and secondary TMA, in which ADAMTS13 activity is not reduced. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.